ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,170Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 890

$970K Total Retail Price of All Prescriptions

Rank: 52 out of 890

705 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 705 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

32% of this provider’s 705 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,354 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 979 760 1 1
HYDROCODONE-ACETAMINOPHEN 949 473 S3 2 3
METFORMIN HCL 513 290 3 6
SIMVASTATIN 504 390 4 5
FUROSEMIDE 501 305 5 7
HYDROCHLOROTHIAZIDE 441 300 6 9
POTASSIUM CHLORIDE 405 289 7 11
NEXIUM 388 154 8 14
METOPROLOL TARTRATE 337 204 9 15
DIOVAN 276 190 10 33
OMEPRAZOLE 272 158 11 8
GABAPENTIN 271 145 12 12
CARVEDILOL 250 192 13 22
CLOPIDOGREL 248 185 14 28
ZOLPIDEM TARTRATE 237 120 15 19
LEVOTHYROXINE SODIUM 227 188 16 2
MELOXICAM 224 134 17 18
DIOVAN HCT 223 134 18 48
LISINOPRIL 189 103 19 4
CLONIDINE HCL 186 117 20 35
GLIMEPIRIDE 177 127 21 27
PLAVIX 169 136 22 42
ALLOPURINOL 168 120 23 31
RANITIDINE HCL 166 108 24 49
ISOSORBIDE MONONITRATE ER 155 122 25 60
SINGULAIR 155 76 25 79
PRAVASTATIN SODIUM 145 107 27 10
CRESTOR 145 73 27 25
WARFARIN SODIUM 144 139 29 24
PROAIR HFA 143 74 30 55
RAMIPRIL 141 62 31 80
SPIRIVA 139 72 32 66
GLYBURIDE 136 74 R 33 83
PANTOPRAZOLE SODIUM 135 98 34 34
TAMSULOSIN HCL 130 119 35 32
TIZANIDINE HCL 126 51 36 106
METOPROLOL SUCCINATE 125 107 37 17
ENALAPRIL MALEATE 120 62 38 56
PHENYTOIN SODIUM EXTENDED 119 70 39 111
JANUVIA 118 54 40 59
ATORVASTATIN CALCIUM 113 81 41 13
AMLODIPINE BESYLATE-BENAZEPRIL 108 93 42 41
ESCITALOPRAM OXALATE 100 48 43 51
LACTULOSE 99 58 44 112
NABUMETONE 99 46 44 143
HYDRALAZINE HCL 95 64 46 100
CITALOPRAM HBR 92 68 47 20
LOVASTATIN 89 89 48 46
TRAMADOL HCL 88 40 49 16
LANTUS 87 54 50 50
LYRICA 86 35 51 71
SERTRALINE HCL 86 43 51 26
AMITRIPTYLINE HCL 84 51 R 53 43
FLUTICASONE PROPIONATE 82 39 54 39
MONTELUKAST SODIUM 80 36 55 130
ACTOS 77 63 56 88
VENTOLIN HFA 75 36 57 177
NAPROXEN 74 32 58 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 45 59 21
NAMENDA 71 71 60 36
QUETIAPINE FUMARATE 69 33 61 73
ENABLEX 68 67 62 248
CYCLOBENZAPRINE HCL 66 28 R 63 64
AZITHROMYCIN 66 39 63 37
NASONEX 64 17 65 170
CLOTRIMAZOLE-BETAMETHASONE 63 28 66 152
PROMETHAZINE HCL 62 23 R 67 104
INSULIN SYRINGE 60 28 68 99
BUSPIRONE HCL 58 26 69 133
TEKTURNA 58 46 69 247
DOXAZOSIN MESYLATE 57 29 71 70
LIPITOR 57 45 71 77
ZETIA 56 49 73 81
DILTIAZEM 24HR ER 54 42 74 149
MUPIROCIN 54 28 74 121
EXFORGE 54 37 74 140
LUNESTA 52 32 77 283
MECLIZINE HCL 51 39 78 97
RISPERIDONE 51 31 78 78
GLIPIZIDE 51 23 78 62
KLOR-CON M20 51 37 78 72
FAMOTIDINE 50 48 82 90
MEGESTROL ACETATE 50 21 R 82 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.